Equity Research, Broker Reports, and media content on Oncimmune

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oncimmune
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oncimmune. We currently have 47 research reports from 6 professional analysts.

Open
N/A
Range Today
N/A
52 Week
31.5/109p
Daily Volume
N/A
# Shares
63.5m
Daily Liquidity
(0.00%)
Pension Liability
£0m
Enterprise Value
£35.8m
Market Cap
£30.2m
Latest PE (hist)
Div Yield
Date Source Announcement
01Apr20 10:31 RNS PDMR Dealing
25Mar20 12:42 RNS PDMR Dealing
20Mar20 14:09 RNS Holding(s) in Company
18Mar20 17:42 RNS Holding(s) in Company
18Mar20 12:19 RNS PDMR Dealing
17Mar20 10:24 RNS NICE concludes review of EarlyCDT Lung
13Mar20 11:42 RNS Issue of Equity
  • Frequency of research reports

     

  • Research reports on

    Oncimmune

  • Providers covering

    Oncimmune